As SVP and CIO of Capital BlueCross, Mark Caron has been focused on leading the health insurer's efforts to leverage data and analytics to develop tools that can help people understand more about their health and "live better." Caron now will be approaching this mission from a different platform in his new role as CEO of Geneia, part of the Capital BlueCross (Harrisburg, Pa.) family of companies. Describing itself as "a healthcare innovations company," Geneia specializes in the development of advanced clinical, analytical, and technical solutions for healthcare, with a focus on improving costs, quality and accessibility.
[Caron oversaw development of analytics capabilities to provide consumers with medical value in a market transformed by healthcare reform: Capital BlueCross' Mark Caron Thrives On The Challenge Of Change]
"Mark's extensive experience and thought leadership in this industry and in particular, the quickly evolving discipline of data and analytics, position him extremely well to assume this role and lead a company that is developing innovative solutions to address the emerging needs of a rapidly changing market," said Gary D. St. Hilaire, President and CEO of Capital BlueCross, in a company statement. "I look forward to Mark's leadership as Geneia expands its footprint and drives new and more effective ways for the healthcare industry to shape healthier outcomes and higher levels of patient satisfaction."